Skip to main content
. Author manuscript; available in PMC: 2013 Nov 7.
Published in final edited form as: J Clin Oncol. 2004 Nov 1;22(21):10.1200/JCO.2004.09.096. doi: 10.1200/JCO.2004.09.096

Fig 4.

Fig 4

Pharmacokinetic profiles of fenretinide (4-HPR) and N-(4-methoxyphenyl)-retinamide (4-MPR) in 26 patients. Plasma samples were obtained on day 1, course 1 at 0, 1, 3, 6, 9, and 12 hours, and trough levels at 24 hours, days 14 (336 hours) and 21 (504 hours) after the first administration of fenretinide at a dose of 600 mg/m2.